株式会社Veritas In Silico Logo

株式会社Veritas In Silico

A drug discovery company developing mRNA-targeting therapeutics using an AI platform.

130A | T

Overview

Corporate Details

ISIN(s):
JP3155340007
LEI:
Country:
Japan
Address:
品川区西五反田一丁目11番1号

Description

Veritas In Silico Inc. is a drug discovery company that specializes in developing therapeutics targeting messenger RNA (mRNA). The company utilizes its proprietary, AI-driven integrated drug discovery platform, ibVIS®, for in silico target identification and high-throughput screening. Its primary focus is on creating innovative small molecule drugs and nucleic acid medicines. Veritas In Silico operates through a collaborative business model, engaging in joint research and development partnerships with pharmaceutical companies to discover and develop novel treatments for various diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:00
半期報告書-第10期(2025/01/01-2025/12/31)
Japanese 177.7 KB
2025-08-14 08:00
確認書
Japanese 8.8 KB
2025-03-28 05:18
臨時報告書
Japanese 27.1 KB
2025-03-28 02:47
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-28 02:47
確認書
Japanese 8.8 KB
2025-03-28 02:46
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 3.1 MB
2024-08-14 08:00
確認書
Japanese 8.7 KB
2024-08-14 08:00
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 171.1 KB
2024-05-15 09:55
確認書
Japanese 8.7 KB
2024-05-15 08:00
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 146.8 KB
2024-03-15 07:01
臨時報告書
Japanese 23.2 KB
2024-03-15 07:00
有価証券報告書-第8期(2023/01/01-2023/12/31)
Japanese 3.1 MB
2024-02-08 01:05
臨時報告書
Japanese 21.1 KB
2024-01-31 07:00
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-23 07:00
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB

Automate Your Workflow. Get a real-time feed of all 株式会社Veritas In Silico filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社Veritas In Silico

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社Veritas In Silico via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.